igCon Therapeutics Co., Ltd. Details
- Country/Region:China
- Business Type:Trading Company
- Year Established:1996
- Number Of Employees:51 - 100
- Total Annual Sales Volume:USD 100,000 - 500,000
- Main Products:Cardiac Infarction, Test Kit
- Address:Bldg.B563 Song Tao Rd.,Suite 320 Zhangjiang Shenyang Liaoning China
About Us
Lgcon is a joint venture of GENETASTIX Corp,USA,and Shanghai Southern Gene Co.Ltd,China,the subsidiary of Chinese National Human Genome Center at Shanghai.igCon Therapeutics Co., Ltd. first biotech company in China that dedicates to the development of fully-humanized antibody therapeutics for global market.
Our Products and Services
Fully-humanized antibody therapeutics for cancers and autoimmune diseases
Humanized and mouse antibody reagents for functional genomics R&D
Antibodies for clinical diagnostics
Mammalian cell lines expressing recombinant humanized antibodies
Laboratory animal testing services for drug validation and preclinical studies
Service of generating customer-made humanized or mouse antibody libraries
Category
Related Product